Pediatrix Medical Group, Inc. (NYSE:MD) Stake Increased by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust lifted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD) by 36.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,919 shares of the company’s stock after buying an additional 1,040 shares during the period. Parkside Financial Bank & Trust’s holdings in Pediatrix Medical Group were worth $51,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Quest Partners LLC increased its stake in Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after buying an additional 622 shares during the period. Everence Capital Management Inc. increased its stake in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after acquiring an additional 960 shares during the last quarter. Quarry LP increased its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after acquiring an additional 1,662 shares during the last quarter. Atria Investments Inc raised its holdings in shares of Pediatrix Medical Group by 9.0% during the third quarter. Atria Investments Inc now owns 27,124 shares of the company’s stock worth $314,000 after acquiring an additional 2,238 shares in the last quarter. Finally, Illinois Municipal Retirement Fund boosted its position in Pediatrix Medical Group by 7.8% during the fourth quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company’s stock valued at $622,000 after purchasing an additional 3,411 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Down 2.1 %

Shares of MD stock opened at $14.46 on Tuesday. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a market cap of $1.24 billion, a PE ratio of -12.05, a price-to-earnings-growth ratio of 1.74 and a beta of 1.57. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The business’s 50 day moving average is $13.99 and its two-hundred day moving average is $13.19.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on MD shares. Deutsche Bank Aktiengesellschaft upped their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. UBS Group raised their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Macquarie initiated coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 target price for the company. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Finally, Jefferies Financial Group lifted their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, Pediatrix Medical Group presently has an average rating of “Hold” and a consensus target price of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.